HCP Live
Nuerology Live
Contagion Live
OncLive
Neurology Live
Neurology Live
Spotlight
Clinical Focus
Video Series
Media
Conferences
Partners
Resources
Subscribe
  • Advertise
  • Contact Us
  • Editorial
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy

© 2021 MJH Life Sciences and Neurology Live. All rights reserved.

Spotlight
  • AES 2020
Clinical FocusSee All >
  • Dementia/Alzheimer
  • Epilepsy
  • Headache/Migraine
  • Movement Disorders
  • Multiple Sclerosis
  • Neuromuscular
  • Sleep Medicine
  • Stroke
Video Series
  • Cure Connections
  • Insights
  • News Network
  • Peer Exchange
  • Advertise
  • Contact Us
  • Editorial
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy
  • MJHLS Brand Logo

© 2021 MJH Life Sciences™ and Neurology Live. All rights reserved.

Management of Cardiac Amyloidosis

Cardiac Amyloidosis Diagnostic Workup

Hypertrophic Cardiomyopathy Historical Prognosis

AL and ATTR Diagnosis: Echo and Noncardiac Biopsy

When Are Heart Biopsies Warranted?

Technetium Pyrophosphate Scan Benefits

Monoclonal Protein Testing and Wild-Type ATTR

Technetium Pyrophosphate Scan Prior to TAVR

AL and ATTR Survival Metrics

Poor Toleration: AL and ATTR Treatment Modification

Cardioversion and Atrial Fibrillation Ablation

Cardiac Amyloidosis: Pacemakers and Defibrillators

Therapy Selection for Congestive Heart Failure

Available ATTR Selective Stabilizers

Cardiomyopathy Management: NSAID Options

TTR Gene Silencers as Cardiomyopathy Treatment

Developing Agents for Cardiac Amyloidosis Management